You can use Gemini Enterprise to get feedback on a pitch deck, for message
clarity and to brainstorm potential questions.

## Example prompt

In the chat box, enter a prompt such as the following:

    Please review the [ATTACHED PITCH] for Cymbal Labs [PRODUCT] for [CUSTOMER]. I
    need your feedback on three things:

    1. Product & Value Clarity: Does the pitch clearly communicate the product's
    value to [CUSTOMER]?

    2. Messaging Improvements: What specific parts of the messaging can be improved
    for clarity or impact?

    3. Anticipated Questions: What questions or objections might [CUSTOMER] have
    after reading this?

## Example output

In response to this prompt, Gemini Enterprise produces output similar to the
following:
> After reviewing your introductory pitch for Apex Pharmaceuticals, here is my feedback on the three areas you requested.
>
> Overall, this is a very strong, data-driven pitch that effectively communicates a compelling ROI. The feedback below is intended to help you refine it to be even more impactful.
>
> *** ** * ** ***
>
> ### 1. Product \& Value Clarity
>
> The pitch does an excellent job of communicating the product and its value.
>
> - **Product Clarity: High.** The presentation clearly identifies the product as "Cymbal Labs 'Synapse' R\&D Intelligence Platform." Page 3 ("Accelerating Drug Discovery") is particularly effective at explaining what the product does by showing a clear, step-by-step evolution of capabilities from basic literature search to fully predictive, AI-driven research modeling.
>
> - **Value Clarity: Excellent.** The value proposition is the strongest part of the pitch. It is clear, quantitative, and directly tied to Apex Pharmaceuticals' business objectives.
>
>   - The **three core value drivers** on page 4 (Accelerated Compound Screening, De-risked Clinical Pathways, Enhanced IP Moat) are concise and powerful.
>   - The **$150M+ pipeline value acceleration** and **5.2x ROI** figures are attention-grabbing and make the value immediately obvious.
>   - The **"Low Break Even" slide (Page 7)** is a brilliant touch, as it effectively minimizes the perceived risk of the investment by showing that only a very small improvement (a 0.5% increase in successful pre-clinical candidates) is needed to cover the cost.
>
> *** ** * ** ***
>
> ### 2. Messaging Improvements
>
> The messaging is professional and compelling. Here are a few suggestions to enhance its clarity and impact.
>
> | Section | Suggested Improvement | Rationale |
> |---|---|---|
> | **Value Drivers (Page 4)** | Frame the exclusion of downstream revenue from approved drugs more positively. For example: "This 5.2x ROI is based purely on R\&D operational efficiency. **Additional value, not included in this calculation**, comes from increased patent licensing opportunities and first-mover market advantages." | This turns a disclaimer into an additional selling point, suggesting the true ROI is even higher. |
> | **"Automated Hypothesis Generation" (Page 3)** | Consider renaming "Automated Hypothesis Generation" to something more descriptive of the user benefit, such as **"Predictive Molecule Design"** or **"Intelligent Pathway Modeling."** | The term "Automated Hypothesis Generation" might be unfamiliar jargon to a business audience. Focusing on the outcome makes the benefit more immediate and understandable. |
> | **"Cymbal's proprietary genomic and proteomic datasets" (Page 4)** | Be prepared to elaborate on this. Consider adding a short, reassuring note like: "...powered by Cymbal's anonymized and ethically sourced clinical trial and molecular data signals." | This is Cymbal's "secret sauce," but it can also create uncertainty. A brief, proactive clarification can build trust and pre-empt questions about data privacy and usage. |
> | **Pricing Slide (Page 8)** | Move the detailed pricing slide to an appendix. Keep it in your back pocket for the Q\&A. | The slide is dense and complex. Introducing it too early can distract from the value proposition you have just built. |
>
> *** ** * ** ***
>
> ### 3. Anticipated Questions
>
> ...